Generic price reporting lawsuit
Executive Summary
Generic Pharmaceutical Association criticizes Massachusetts Attorney General's Sept. 25 civil lawsuit against 13 generic firms regarding fraudulent price reporting. The suit is "counter-productive when more constructive ways of seeking lower spending, such as increasing generic pharmaceutical utilization and access to generic medicines, can deliver immediate and substantial additional savings to consumers and state governments," GPhA says. Massachusetts claims the state Medicaid program lost over $50 mil. due to drug "marketing and pricing schemes"...
You may also be interested in...
European CHMP Opinions and MAA Updates
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the European Union, and updates on EU marketing authorization changes recommended by the CHMP.
UK’s NICE Backs Two Microsphere Products For Liver Cancer But Says No To Another
Health technology assessment body NICE has now recommended that selective internal radiation therapy can be used on England’s National Health Service for treating advanced liver cancer.
EU ‘Structured Dialog’ Offers Opportunity To Secure Supply
A “structured dialog” led by the European Commission with pharmaceutical industry stakeholders provides a critical opportunity to address weaknesses in the stability and security of the supply chain by improving the environment for local manufacturing, Medicines for Europe believes.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: